Literature DB >> 19161338

TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.

Jason Baardsnes1, Cynthia S Hinck, Andrew P Hinck, Maureen D O'Connor-McCourt.   

Abstract

The TGF-beta isoforms, TGF-beta1, -beta2, and -beta3, share greater than 70% sequence identity and are almost structurally identical. TGF-beta2 differs from the others, however, in that it binds the TGF-beta type II receptor (TbetaR-II) with much lower affinity than either TGF-beta1 or -beta3. It has been previously shown that three conserved interfacial residues, Arg25, Val92, Arg94, in TGF-beta1 and -beta3 are responsible for their high-affinity interaction with TbetaR-II. In this study, the role of each of these residues was examined by creating single, double, and triple substitutions resulting in both TGF-beta3 loss-of-function and TGF-beta2 gain-of-function variants. One-dimensional 1H NMR spectra of the variants confirmed a lack of large structural perturbations. Affinities, kinetics, and thermodynamics for TbetaR-II binding were determined by surface plasmon resonance biosensor analysis. Double substitutions revealed that nearly all of the high-affinity binding is contributed by Arg25 and Arg94. Single site substitutions showed that Arg94 makes the greatest contribution. Substitution of Arg25 and Arg94 with alanine verified the requirement of the arginine guanidinium functional groups for the highly specific hydrogen-bonded ion pairs formed between Arg25 and Arg94 of TGF-beta1 and -beta3, and Glu119 and Asp32 of TbetaR-II. Further kinetic and thermodynamic analyses confirmed that Arg25 and Arg94 are primarily responsible for high-affinity binding and also revealed that noninterfacial longer range effects emanating from the TGF-beta structural framework contribute slightly to TbetaR-II binding. Growth inhibition assays showed that binding changes generally correlate directly with changes in function; however, a role Val92 in this cellular context was uncovered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19161338      PMCID: PMC2801812          DOI: 10.1021/bi8019004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-beta type II receptor.

Authors:  A P Hinck; K P Walker; N R Martin; S Deep; C S Hinck; D I Freedberg
Journal:  J Biomol NMR       Date:  2000-12       Impact factor: 2.835

2.  Proteinminus signProtein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis.

Authors:  Wesley E. Stites
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

Review 3.  Interpretation of the temperature dependence of equilibrium and rate constants.

Authors:  Donald J Winzor; Craig M Jackson
Journal:  J Mol Recognit       Date:  2006 Sep-Oct       Impact factor: 2.137

Review 4.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 5.  TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring.

Authors:  Kenneth R Cutroneo
Journal:  Wound Repair Regen       Date:  2007 Sep-Oct       Impact factor: 3.617

Review 6.  TGF-beta-receptor-mediated signaling.

Authors:  R Derynck
Journal:  Trends Biochem Sci       Date:  1994-12       Impact factor: 13.807

7.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions.

Authors:  M Piotto; V Saudek; V Sklenár
Journal:  J Biomol NMR       Date:  1992-11       Impact factor: 2.835

8.  Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.

Authors:  Jay Groppe; Cynthia S Hinck; Payman Samavarchi-Tehrani; Chloe Zubieta; Jonathan P Schuermann; Alexander B Taylor; Patricia M Schwarz; Jeffrey L Wrana; Andrew P Hinck
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

9.  Enhancement of the antagonistic potency of transforming growth factor-beta receptor extracellular domains by coiled coil-induced homo- and heterodimerization.

Authors:  Gregory De Crescenzo; Phuong L Pham; Yves Durocher; Heman Chao; Maureen D O'Connor-McCourt
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

10.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

Authors:  L P Sanford; I Ormsby; A C Gittenberger-de Groot; H Sariola; R Friedman; G P Boivin; E L Cardell; T Doetschman
Journal:  Development       Date:  1997-07       Impact factor: 6.868

View more
  27 in total

Review 1.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

2.  TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.

Authors:  Tao Huang; Laurent David; Valentín Mendoza; Yong Yang; Maria Villarreal; Keya De; LuZhe Sun; Xiaohong Fang; Fernando López-Casillas; Jeffrey L Wrana; Andrew P Hinck
Journal:  EMBO J       Date:  2011-03-18       Impact factor: 11.598

3.  Slow, reversible, coupled folding and binding of the spectrin tetramerization domain.

Authors:  S L Shammas; J M Rogers; S A Hill; J Clarke
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

4.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

Review 5.  Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family.

Authors:  Sun Kyung Kim; Morkos A Henen; Andrew P Hinck
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-10

6.  Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.

Authors:  Kazuki Takahashi; Yuichi Akatsu; Katarzyna A Podyma-Inoue; Takehisa Matsumoto; Hitomi Takahashi; Yasuhiro Yoshimatsu; Daizo Koinuma; Mikako Shirouzu; Kohei Miyazono; Tetsuro Watabe
Journal:  J Biol Chem       Date:  2020-07-06       Impact factor: 5.157

Review 7.  Structure-guided engineering of TGF-βs for the development of novel inhibitors and probing mechanism.

Authors:  Andrew P Hinck
Journal:  Bioorg Med Chem       Date:  2018-07-07       Impact factor: 3.641

8.  The TβR-I pre-helix extension is structurally ordered in the unbound form and its flanking prolines are essential for binding.

Authors:  Jorge E Zuniga; Udayar Ilangovan; Pardeep Mahlawat; Cynthia S Hinck; Tao Huang; Jay C Groppe; Donald G McEwen; Andrew P Hinck
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

9.  Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.

Authors:  Sergei Radaev; Zhongcheng Zou; Tao Huang; Eileen M Lafer; Andrew P Hinck; Peter D Sun
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

10.  Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor.

Authors:  Valentín Mendoza; M Magdalena Vilchis-Landeros; Guillermo Mendoza-Hernández; Tao Huang; Maria M Villarreal; Andrew P Hinck; Fernando López-Casillas; Jose-Luis Montiel
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.